Post-operative radiotherapy for ductal carcinoma in situ of the breast - A systematic review of the randomised trials

Breast

Volumn 18, Issue 3, 2009, Pages 143-149

  Goodwin, Annabel ^a   Parker, Sharon ^b   Ghersi, Davina ^b   Wilcken, Nicholas ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Ductal carcinoma in situ; Meta analysis; Radiotherapy

Indexed keywords

TAMOXIFEN;

BONE CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEATH; DRUG EFFICACY; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; HUMAN; INTRADUCTAL CARCINOMA; LUNG CANCER; LUNG TOXICITY; PARTIAL MASTECTOMY; POSTOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; REVIEW; RISK REDUCTION; SECOND CANCER; SOFT TISSUE CANCER; SYSTEMATIC REVIEW; VASCULAR DISEASE;

EID: 67349130739     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2009.04.003     Document Type: Review

References (12)

1. Burstein H.J., Polyak K., Wong J.S., Lester S.C., Kaelin C.M., Burstein H.J., et al. Ductal carcinoma in situ of the breast. N Engl J Med 350 14 (2004 Apr 1) 1430-1441
2. Anon. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 355 9217 (2000 May 20) 1757-1770
3. Higgins J., and Green S. Cochrane handbook for systematic reviews of interventions. Version 5.0.0 [updated February 2008] (2008), The Cochrane Collaboration. Available from: www.cochrane-handbook.org
4. Parmar M.K., Torri V., and Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. [erratum appears in Stat Med. 2004 Jun 15;23(11):1817]. Stat Med 17 24 (1998 Dec 30) 2815-2834
5. Fisher B., Land S., Mamounas E., Dignam J., Fisher E.R., and Wolmark N. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 28 4 (2001 Aug) 400-418
6. Holmberg L., Garmo H., Granstrand B., Ringberg A., Arnesson L.G., Sandelin K., et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol 26 8 (2008 Mar 10) 1247-1252
7. Houghton J., George W.D., Cuzick J., Duggan C., Fentiman I.S., Spittle M., et al. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362 9378 (2003 Jul 12) 95-102
8. Group E.B.C.C., Group E.R., Bijker N., Meijnen P., Peterse J.L., Bogaerts J., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853 - a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 24 21 (2006 Jul 20) 3381-3387
9. Fisher E.R., Dignam J., Tan-Chiu E., Costantino J., Fisher B., Paik S., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 86 3 (1999 Aug 1) 429-438
10. Fisher B., Dignam J., Wolmark N., Mamounas E., Costantino J., Poller W., et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16 2 (1998 Feb) 441-452
11. Julien J.P., Bijker N., Fentiman I.S., Peterse J.L., Delledonne V., Rouanet P., et al., EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet 355 9203 (2000 Feb 12) 528-533
12. Hooning M.J., Aleman B.M.P., Hauptmann M., Baaijens M.H.A., Klijn J.G.M., Noyon R., et al. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer. J Clin Oncol (2008)